SEGMENT AND GEOGRAPHIC INFORMATION

The Company internally manages two global reportable segments and reports the results of its businesses to its chief operating decision maker. The two reportable segments and their activities are described below.

•

The Codman Specialty Surgical segment includes (i) the Neurosurgery business, which sells a full line of products for neurosurgery and neuro critical care such as tissue ablation equipment, dural repair products, cerebral spinal fluid management devices, intracranial monitoring equipment, and cranial stabilization equipment and (ii) the precision tools and instruments business, which sells more than 60,000 instrument patterns and surgical and lighting products to hospitals, surgery centers, dental, podiatry, and veterinary offices.


•	The Orthopedics and Tissue Technologies segment includes such offerings as skin and wound repair, bone and joint fixation implants in the upper and lower extremities, bone grafts and nerve and tendon repair products.

The Corporate and other category includes (i) various executive, finance, human resource, information systems, legal functions, (ii) brand management, and (iii) share-based compensation costs.

The operating results of the various reportable segments as presented are not comparable to one another because (i) certain operating segments are more dependent than others on corporate functions for unallocated general and administrative and/or operational manufacturing functions and (ii) the Company does not allocate certain manufacturing costs and general and administrative costs to the operating segment results. Net sales and profit by each reportable segment for the three months ended March 31, 2019 and 2018 are as follows:



	Three Months Ended March 31,
	2019			2018
	(In thousands)
Segment Net Sales
Codman Specialty Surgical	$	234,568		$	236,115
Orthopedics and Tissue Technologies	125,122			120,967
Total revenues	$	359,690		$	357,082
Segment Profit
Codman Specialty Surgical	$	91,380		$	89,491
Orthopedics and Tissue Technologies	40,495			32,438
Segment profit	131,875			121,929
Amortization	(5,279		)	(5,390)
Corporate and other	(94,288		)	(90,960		)
Operating income	$	32,308		$	25,579

The Company does not allocate any assets to the reportable segments. No asset information is reported to the chief operating decision maker and disclosed in the financial information for each segment.

The Company attributes revenues to geographic areas based on the location of the customer. Total revenue by major geographic area consisted of the following:



	Three Months Ended March 31,
	2019		2018
	(In thousands)
United States	$	256,726	$	248,928
Europe	48,640		51,773
Asia Pacific	35,700		35,785
Rest of World	18,624		20,596
Total Revenues	$	359,690	$	357,082